1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics

Chronic Disease Analysis & Statistics

1-15 of 15 reports

Malignant Pleural Effusion - Global Clinical Trials Review, H2, 2021

  • $ 2500
  • October 2021
  • 128 pages

Malignant Pleural Effusion - Global Clinical Trials Review, H2, 2021 Summary clinical trial report, “Malignant Pleural Effusion - Global Clinical Trials Review, H2, 2021" provides an overview of ...

  • World
  • Respiratory Disease
  • Clinical Trial
  • Industry analysis
  • Smoking Prevalence

Atrial Flutter - Global Clinical Trials Review, H2, 2021

  • $ 2500
  • August 2021
  • 128 pages

Atrial Flutter - Global Clinical Trials Review, H2, 2021 Summary clinical trial report, “Atrial Flutter - Global Clinical Trials Review, H2, 2021" provides an overview of Atrial Flutter Clinical ...

  • World
  • Cardiovascular Disease
  • Clinical Trial
  • Industry analysis
  • Surgical Procedures Performed

Fibromyalgia - Competitive Landscape in 2021

  • $ 3495
  • June 2021
  • 45 pages

Fibromyalgia - Competitive Landscape in 2021 Summary This reports provides a data-driven overview of the current and future competitive landscape in fibromyalgia therapeutics. In fibromyalgia Cannabinoid ...

  • World
  • Chronic Pain
  • Industry analysis
  • Prescription Drug Sales
  • Drug Approval

Dyslipidemia - Competitive Landscape in 2021

  • $ 3495
  • June 2021
  • 51 pages

Dyslipidemia - Competitive Landscape in 2021 Summary This reports provides a data-driven overview of the current and future competitive landscape in dyslipidemia therapeutics. In dyslipidemia 3 ...

  • World
  • Cholesterol
  • Industry analysis
  • Prescription Drug Sales
  • Advertising Expenditure

Polycystic Kidney Disease - Global Clinical Trials Review, H1, 2021

  • $ 2500
  • June 2021
  • 146 pages

Polycystic Kidney Disease - Global Clinical Trials Review, H1, 2021 Summary clinical trial report, “Polycystic Kidney Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Polycystic ...

  • World
  • Renal Disease
  • Clinical Trial
  • Industry analysis
  • Stem Cell Transplantation

Diabetic Foot Infection (DFI) - Global Clinical Trials Review, H1, 2021

  • $ 2500
  • June 2021
  • 94 pages

Diabetic Foot Infection (DFI) - Global Clinical Trials Review, H1, 2021 Summary clinical trial report, “Diabetic Foot Infection (DFI) - Global Clinical Trials Review, H1, 2021" provides an overview ...

  • World
  • Clinical Trial
  • Diabetes
  • Industry analysis
  • Medical Technology Density

Diabetic Foot Ulcers - Global Clinical Trials Review, H1, 2021

  • $ 2500
  • June 2021
  • 275 pages

Diabetic Foot Ulcers - Global Clinical Trials Review, H1, 2021 Summary clinical trial report, “Diabetic Foot Ulcers - Global Clinical Trials Review, H1, 2021" provides an overview of Diabetic Foot Ulcers ...

  • World
  • Type 2 Diabetes
  • Clinical Trial
  • Industry analysis

Predigen Inc - Product Pipeline Analysis, 2021 Update

  • $ 750
  • October 2021
  • 26 pages

Summary Predigen Inc (Predigen) develops host gene expression signatures based on predictive response for use in prognostic, diagnostic, and therapeutic monitoring tools.The company offers testing products ...

  • United States
  • World
  • Cardiovascular Disease
  • Clinical Trial
  • Industry analysis
  • Medical Devices Sales

Immunodiagnostic Systems Holdings plc - Product Pipeline Analysis, 2021 Update

  • $ 750
  • August 2021
  • 39 pages

Summary Immunodiagnostic Systems Holdings Ltd (IDS) is an in-vitro diagnostic solution provider.The company develops, manufactures, and markets immunoassays and automated immunoanalyser technologies. It ...

  • APAC
  • Diagnostics
  • Infectious Disease
  • Annual report
  • Company
  • Direct Sales
  • Medical Devices Sales

DePuy Synthes Inc - Product Pipeline Analysis, 2021 Update

  • $ 750
  • August 2021
  • 49 pages

Summary DePuy Synthes Inc (DePuy Synthes), a subsidiary of Johnson & Johnson, is a medical device company that provides products for orthopedic procedures.The company offers orthopaedic products and services ...

  • World
  • United States
  • Orthopedics
  • Medical Device
  • Industry analysis
  • Surgical Procedures Performed
  • Drug Approval

Medtronic Plc (MDT) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • July 2021
  • 279 pages

Summary Medtronic Plc (Medtronic), formerly Medtronic Inc, is a medical technology company that designs, develops, manufactures and markets a wide range of medical devices and solutions for the treatment ...

  • Barbados
  • Clinical Trial
  • Cardiovascular Disease
  • Industry analysis
  • Health Provider Density
  • Diabetes Prevalence

Micronics Inc - Product Pipeline Analysis, 2021 Update

  • $ 750
  • June 2021
  • 37 pages

Summary Micronics Inc (Micronics) is a medical device company that develops and markets in vitro diagnostic products.The company provides products that include aborhcard and pannat system. Its research ...

  • United States
  • World
  • Respiratory Disease
  • Industry analysis
  • Medical Devices Sales

SomaLogic Inc - Product Pipeline Analysis, 2021 Update

  • $ 750
  • June 2021
  • 80 pages

Summary SomaLogic Inc (SomaLogic) is a precision health company that discovers, develops and commercializes life science research tools and clinical diagnostic tests.It provides SOMAscan assay, a proteomics ...

  • United States
  • North America
  • Cancer
  • Cardiovascular Disease
  • Industry analysis
  • Medical Devices Sales

Nevro Corp (NVRO) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • June 2021
  • 47 pages

Summary Nevro Corp (Nevro) is a medical device company, which strives to provide novel products that advance the quality of life for people suffering from chronic pain in trunks and limbs.The company has ...

  • World
  • North America
  • Chronic Pain
  • Clinical Trial
  • Investor presentation
  • Company
  • Drug Approval
  • Medical Devices Sales

Respiratory Syncytial Virus Prophylaxis - Global Drug Forecast and Market Analysis to 2030

  • $ 10995
  • August 2021
  • 133 pages

Respiratory Syncytial Virus Prophylaxis - Global Drug Forecast and Market Analysis to 2030 Summary Human respiratory syncytial virus (RSV) is an enveloped, single-stranded, negative-sense RNA orthopneumovirus ...

  • World
  • Therapy
  • Pathology
  • Industry analysis
  • Birth Rate
  • Perinatal Mortality



Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on